Laurion Capital Management’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Laurion Capital Management’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-14,158	Closed	-$264K	–	754
2022 Q1	$264K	Sell	14,158 -18,010	-56%	-$324K	﹤0.01%	452
2021 Q4	$688K	Sell	32,168 -44,969	-58%	-$886K	0.01%	388
2021 Q3	$1.43M	Sell	77,137 -39,041	-34%	-$786K	0.01%	482
2021 Q2	$2.49M	Sell	116,178 -93,822	-45%	-$1.91M	0.01%	348
2021 Q1	$4.05M	Buy	+210,000	New	+$3.7M	0.02%	356

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Laurion Capital Management's OCDX Position: Q2 2022 in Review

Laurion Capital Management sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 14,158 shares — an estimated $264K sold.

Laurion Capital Management first reported a position in OCDX in Q1 2021 and held it in 5 quarters. The position peaked at $4.05M in Q1 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

Laurion Capital Management reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Laurion Capital Management sold 14,158 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $264K.
Laurion Capital Management first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 5 quarters.
Laurion Capital Management's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $4.05M in Q1 2021.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Laurion Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.